(Q44223633)

1 December 2017

title

Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women (English)

1 reference

1 December 2017

Voipio SK

1

1 reference

1 December 2017

Komi J

2

1 reference

1 December 2017

Kangas L

3

1 reference

1 December 2017

Halonen K

4

1 reference

1 December 2017

DeGregorio MW

5

1 reference

1 December 2017

Erkkola RU

6

1 reference

1 December 2017

publication date

1 November 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

43

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

207-214

1 reference

Post-menopausal women and osteoporosis: available choices for maintenance of skeletal health

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Benefits and risks of estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Comparison between the Effects of Tamoxifen and Toremifene on the Uterus in Postmenopausal Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Effects of raloxifene hydrochloride on the endometrium of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Hormonal effects of toremifene in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

A comparative study of the estrogenic effects of tamoxifen and 17 beta-estradiol in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900206-2

7 January 2021

10.1016/S0378-5122(02)00206-2

Identifiers

DOI

1 reference

1 December 2017

1 reference